Cargando…
Treatment‐emergent central sleep apnoea managed by CPAP with adjunctive acetazolamide: A case report
Treatment‐emergent central sleep apnoea (TECSA) refers to the emergence of central apnoea during treatment for obstructive sleep apnoea (OSA), most commonly continuous positive airway pressure (CPAP). It has been reported in 8% of OSA patients treated with CPAP and spontaneous resolution rate varies...
Autores principales: | Kwok, Chin Tong, Wong, Kam Cheung, Kwok, Chun Lee, Lee, Sing Hang, Yee, Kwok Sang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882855/ https://www.ncbi.nlm.nih.gov/pubmed/35251664 http://dx.doi.org/10.1002/rcr2.916 |
Ejemplares similares
-
From CPAP to tailored therapy for obstructive sleep Apnoea
por: Sutherland, Kate, et al.
Publicado: (2018) -
Non-CPAP therapy for obstructive sleep apnoea
por: Verbraecken, Johan, et al.
Publicado: (2022) -
Impact of Acetazolamide and CPAP on Cortical Activity in Obstructive Sleep Apnea Patients
por: Stadelmann, Katrin, et al.
Publicado: (2014) -
Treatment with CPAP in Elderly Patients with Obstructive Sleep Apnoea
por: Posadas, Tomas, et al.
Publicado: (2020) -
Treatment-emergent central sleep apnoea after surgery for obstructive sleep apnoea
por: TESTANI, E., et al.
Publicado: (2018)